Published in J Virol on September 01, 1986
The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol (1992) 2.80
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol (1995) 2.24
Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol (2002) 1.87
Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol (2004) 1.85
The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles. J Virol (1995) 1.84
Detection of protein similarities using nucleotide sequence databases. Nucleic Acids Res (1988) 1.45
Identification and characterization of a varicella-zoster virus DNA-binding protein by using antisera directed against a predicted synthetic oligopeptide. J Virol (1988) 1.35
Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region. J Clin Microbiol (1995) 1.27
Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA. J Virol (1988) 1.25
Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1. J Virol (1987) 1.20
Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus. J Virol (1996) 1.19
The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J Virol (1990) 1.13
Application of long PCR method of identification of variations in nucleotide sequences among varicella-zoster virus isolates. J Clin Microbiol (1996) 1.13
Transcription from varicella-zoster virus gene 67 (glycoprotein IV). J Virol (1992) 1.06
Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. J Virol (1994) 1.02
Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C. J Virol (1990) 1.02
Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells. J Virol (2006) 1.00
Characterization of an equine herpesvirus type 1 gene encoding a glycoprotein (gp13) with homology to herpes simplex virus glycoprotein C. J Virol (1988) 1.00
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene (1982) 102.30
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
Pattern recognition in nucleic acid sequences. I. A general method for finding local homologies and symmetries. Nucleic Acids Res (1982) 28.51
Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles. Microbiol Rev (1983) 24.58
Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J Virol (1974) 16.33
The structure and isomerization of herpes simplex virus genomes. Cell (1979) 6.79
Extraction of nucleic acids from agarose gels. Anal Biochem (1980) 6.38
"Nonrandom" DNA sequence analysis in bacteriophage M13 by the dideoxy chain-termination method. Proc Natl Acad Sci U S A (1982) 5.90
Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. J Virol (1983) 4.56
Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2. J Gen Virol (1981) 3.70
Structure and function of herpesvirus genomes. I. comparison of five HSV-1 and two HSV-2 strains by cleavage their DNA with eco R I restriction endonuclease. J Virol (1975) 3.32
DNA sequence analysis of an immediate-early gene region of the herpes simplex virus type 1 genome (map coordinates 0.950 to 0.978). J Gen Virol (1982) 3.16
Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. J Infect Dis (1978) 3.00
DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus. J Virol (1978) 2.76
Structure of varicella-zoster virus DNA. J Virol (1981) 2.43
Location and orientation of homologous sequences in the genomes of five herpesviruses. J Gen Virol (1983) 2.29
Plaque dissociation of herpes simplex viruses: biochemical and biological characters of the viral variants. Intervirology (1977) 2.23
Structure of the genome termini of varicella-zoster virus. J Gen Virol (1984) 1.97
Herpesvirus saimiri strain variability. J Virol (1982) 1.80
A 3' co-terminal family of mRNAs from the herpes simplex virus type 1 short region: two overlapping reading frames encode unrelated polypeptide one of which has highly reiterated amino acid sequence. Nucleic Acids Res (1984) 1.78
Development of a live attenuated varicella vaccine. Biken J (1975) 1.74
Molecular cloning and physical mapping of varicella-zoster virus DNA. Proc Natl Acad Sci U S A (1982) 1.60
Genome differences among varicella-zoster virus isolates. J Gen Virol (1983) 1.59
XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome. J Virol (1981) 1.58
Transcription mapping of the varicella-zoster virus genome. J Virol (1985) 1.44
DNA sequence of the major inverted repeat in the varicella-zoster virus genome. J Gen Virol (1985) 1.28
DNA sequence of the US component of the varicella-zoster virus genome. EMBO J (1983) 1.26
Restriction endonuclease analysis of the DNA from varicella-zoster virus: stability of the DNA after passage in vitro. J Gen Virol (1981) 1.21
Fine mapping and sequencing of a variable segment in the inverted repeat region of varicella-zoster virus DNA. J Virol (1985) 1.21
Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient. N Engl J Med (1984) 1.19
Inversion and circularization of the varicella-zoster virus genome. J Virol (1985) 1.17
Equalization of the inverted repeat sequences of the pseudorabies virus genome by intermolecular recombination. Virology (1984) 1.08
Distribution of G + C-rich regions in varicella-zoster virus DNA. J Gen Virol (1985) 0.96
Alterations in the equine herpesvirus 1 genome after in vitro and in vivo virus passage. Infect Immun (1983) 0.96
Mapping of the thymidine kinase genes of type 1 and type 2 herpes simplex viruses using intertypic recombinants. J Gen Virol (1980) 0.92
Errant processing and structural alterations of genomes present in a varicella-zoster virus vaccine. J Virol (1985) 0.88
Effect of an Escherichia coli traD (ts) mutation on MS2 RNA replication. J Gen Virol (1983) 0.78
The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med (1994) 26.24
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Chronic fatigue syndrome: a working case definition. Ann Intern Med (1988) 9.12
Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells. J Virol (1979) 8.05
Finding and applying evidence during clinical rounds: the "evidence cart". JAMA (1998) 7.30
Socioeconomic status and health: what we know and what we don't. Ann N Y Acad Sci (1999) 6.96
Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest (1998) 5.70
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64
Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev (2005) 5.48
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A (1986) 4.89
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA (1999) 4.71
Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis. Proc Natl Acad Sci U S A (1976) 4.62
Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization. N Engl J Med (1987) 4.57
Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med (1996) 4.36
Molecular genetics of herpes simplex virus: demonstration of regions of obligatory and nonobligatory identity within diploid regions of the genome by sequence replacement and insertion. Proc Natl Acad Sci U S A (1978) 4.31
Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J Clin Microbiol (2001) 3.98
Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci U S A (1988) 3.49
Occupational therapy for independent-living older adults. A randomized controlled trial. JAMA (1997) 3.47
Personal health records: a scoping review. J Am Med Inform Assoc (2011) 3.41
Herpes simplex virus proteins: DNA-binding proteins in infected cells and in the virus structure. Virology (1975) 3.41
Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience (2002) 3.22
Mutants of herpes simplex virus types 1 and 2 that are resistant to phosphonoacetic acid induce altered DNA polymerase activities in infected cells. J Gen Virol (1976) 3.21
Research into complementary and alternative medicine: problems and potential. BMJ (2001) 2.97
Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA (1998) 2.94
The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol (1992) 2.80
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74
Varicella-zoster virus transcription in human trigeminal ganglia. Virology (1993) 2.63
A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med (1999) 2.62
Death in the AIDS patient: role of cytomegalovirus. N Engl J Med (1983) 2.61
Altered properties of deoxyribonucleic acid nucleotidyltransferase after infection of mammalian cells with herpes simplex virus. Nature (1966) 2.61
Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol (2001) 2.58
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
Genetic and biochemical studies with herpesvirus. Cold Spring Harb Symp Quant Biol (1975) 2.47
Structure of varicella-zoster virus DNA. J Virol (1981) 2.43
Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry (1989) 2.42
Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA (2001) 2.38
Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis. Lancet (1995) 2.36
Coding strategy of the S genome segment of Hantaan virus. Virology (1986) 2.36
New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet (1980) 2.35
Gastric intramural pH as a predictor of success or failure in weaning patients from mechanical ventilation. Ann Intern Med (1993) 2.29
Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med (1984) 2.26
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25
Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol (1999) 2.25
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25
Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab (1991) 2.23
Mapping of two varicella-zoster virus-encoded genes that activate the expression of viral early and late genes. Virology (1989) 2.22
An approach to evolutionary relationships of mammalian DNA viruses through analysis of the pattern of nearest neighbor base sequences. Cold Spring Harb Symp Quant Biol (1966) 2.20
Propagation and in vitro studies of previously non-cultivable enteral adenoviruses in 293 cells. Lancet (1981) 2.18
Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review. BMJ (2001) 2.15
A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest (1992) 2.13
Regulation of varicella-zoster virus gene expression in human T lymphocytes. J Virol (1992) 2.12
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med (1999) 2.11
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10
Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood (2000) 2.09
Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0. J Virol (1992) 2.09
Acanthamoeba griffini. Molecular characterization of a new corneal pathogen. Invest Ophthalmol Vis Sci (1996) 2.09
Initiation of adenovirus DNA replication: detection of covalent complexes between nucleotide and the 80-kilodalton terminal protein. J Virol (1982) 2.07
Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis (1999) 2.03
Comparison of chlorine and chlorine dioxide disinfection for control of Legionella in a hospital potable water supply. J Hosp Infect (1996) 2.01
Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations. Am J Clin Pathol (1990) 1.99
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology (2000) 1.99
Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol (1994) 1.99
Molecular genetics of herpes simplex virus. III. Fine mapping of a genetic locus determining resistance to phosphonoacetate by two methods of marker transfer. J Virol (1979) 1.97
Non-acanthamoeba amoebic keratitis. J Infect (1997) 1.92
Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia. J Virol (1988) 1.92
Interaction with nucleic acids and stimulation of the viral DNA polymerase by the herpes simplex virus type 1 major DNA-binding protein. J Virol (1984) 1.91
NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med (1988) 1.88
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
Studies on sRNA coded by herpes virus. Cold Spring Harb Symp Quant Biol (1966) 1.85
The medical review article revisited: has the science improved? Ann Intern Med (1999) 1.84
Stimulation of RNA synthesis in L-929 cells by rabbit tumor necrosis factor. Proc Soc Exp Biol Med (1979) 1.83
On the structure, functional equivalence, and replication of the four arrangements of herpes simplex virus DNA. Cold Spring Harb Symp Quant Biol (1979) 1.80
Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1. J Virol (1988) 1.78
Properties of herpesvirus-induced "immediate early" polypeptides. Virology (1980) 1.75
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet (1999) 1.74
Molecular genetics of herpes simplex virus: the terminal a sequences of the L and S components are obligatorily identical and constitute a part of a structural gene mapping predominantly in the S component. Proc Natl Acad Sci U S A (1979) 1.73
Hexavalent capsomers of herpes simplex virus type 2: symmetry, shape, dimensions, and oligomeric status. J Virol (1986) 1.72
Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters. J Virol (1993) 1.71
The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice. J Infect Dis (1999) 1.70
Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. Virology (1994) 1.70
The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter. Virology (1992) 1.69
HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J Exp Med (1998) 1.66
Hantaan virus infection of human endothelial cells. J Virol (1992) 1.65
Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology (1981) 1.65
Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J Pediatr (2005) 1.64